@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix entrez: . @prefix geneProductOf: . @prefix RNA: . @prefix hgnc: . @prefix mesh: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: entrez:183; a Protein: . sub:_2 geneProductOf: hgnc:7889; a RNA: . sub:_3 occursIn: mesh:D009130, species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(EGID:183) -> r(HGNC:NOX1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "1.4" . sub:_4 prov:value "Moreover, in smooth muscle cells, treatment with the growth-promoting agonist angiotensin II upregulated the expression of nox1 while downregulating that of nox4, suggesting that the expression of these proteins may be positively and negatively related, respectively, to smooth muscle cell growth."; prov:wasQuotedFrom pubmed:11788453 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11788453; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:00.187+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }